| Dr Peter Gulati, | |
|
129 W 9th St, Dallas, TX 75208-4416 | |
| (214) 941-0032 | |
| Not Available |
| Full Name | Dr Peter Gulati |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 129 W 9th St, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245349422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K3743 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Dallas Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmed Medical Group Pa | 4880657386 | 693 |
News Archive
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
An outbreak of respiratory tract diseases which can be traced back to an infection with a new type of coronavirus (2019-nCoV) was identified in Asia.
A new report, involving the University of Leicester, has called for greater understanding of how checklists can be used to improve safety. The report has been described as "counter-revolutionary" and providing a "a long overdue and desperately needed reality check for checklists in medicine" by Faculty of 1000 Medicine.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
› Verified 1 days ago
| Entity Name | Wellmed Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437156486 PECOS PAC ID: 4880657386 Enrollment ID: O20041105000519 |
News Archive
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
An outbreak of respiratory tract diseases which can be traced back to an infection with a new type of coronavirus (2019-nCoV) was identified in Asia.
A new report, involving the University of Leicester, has called for greater understanding of how checklists can be used to improve safety. The report has been described as "counter-revolutionary" and providing a "a long overdue and desperately needed reality check for checklists in medicine" by Faculty of 1000 Medicine.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Gulati, Po Box 847293, Dallas, TX 75284-7293 Ph: (214) 941-0032 | Dr Peter Gulati, 129 W 9th St, Dallas, TX 75208-4416 Ph: (214) 941-0032 |
News Archive
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
An outbreak of respiratory tract diseases which can be traced back to an infection with a new type of coronavirus (2019-nCoV) was identified in Asia.
A new report, involving the University of Leicester, has called for greater understanding of how checklists can be used to improve safety. The report has been described as "counter-revolutionary" and providing a "a long overdue and desperately needed reality check for checklists in medicine" by Faculty of 1000 Medicine.
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people's cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
› Verified 1 days ago
Dr. Juan F Quiroz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4811a Columbia Ave, Dallas, TX 75226 Phone: 214-823-5590 Fax: 214-823-6638 | |
Dr. Michelle Dobbs, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6333 E Mockingbird Ln, Suite 126, Dallas, TX 75214 Phone: 214-826-6005 | |
Howard J Huntzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9250 Amberton Pkwy, Dallas, TX 75243 Phone: 682-236-3656 | |
Robert J Dimeff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8081 Walnut Hill Ln, Dallas, TX 75231 Phone: 214-750-1207 Fax: 214-739-5029 | |
Pardeep K Shori, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7012 La Vista Dr, Dallas, TX 75214 Phone: 817-564-5761 | |
Mary Elizabeth Wilcox Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 Fairmount St, Dallas, TX 75201 Phone: 214-742-9310 | |
Elizabeth Chapek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Phone: 214-341-8742 |